The chairman and president of Japanese drug manufacturer Kobayashi Pharmaceutical have stepped down amid an investigation into whether their dietary supplements are linked to hundreds of deaths.
Company Chairman Kazumasa Kobayashi stepped down Tuesday but will stay at the firm as an advisor. His son and president of the company, Akihiro Kobayashi, will also resign but maintain a role to help compensate potential victims.